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ABSTRACT
Clonal level random allelic expression imbalance and random monoallelic expression provides cellular heterogeneity within
tissues by modulating allelic dosage. Although such expression patterns have been observed in multiple cell types, little is
known about when in development these stochastic allelic choices are made. We examine allelic expression patterns in human
neural progenitor cells before and after epigenetic reprogramming to induced pluripotency, observing that loci previously
characterized by random allelic expression imbalance (0.63% of expressed genes) are generally reset to a biallelic state in
induced pluripotent stem cells (iPSCs). We subsequently neuralized the iPSCs and profiled isolated clonal neural stem cells,
observing that significant random allelic expression imbalance is reestablished at 0.65% of expressed genes, including novel
loci not found to show allelic expression imbalance in the original parental neural progenitor cells. Allelic expression
imbalance was associated with altered DNA methylation across promoter regulatory regions, with clones characterized by
skewed allelic expression being hypermethylated compared to their biallelic sister clones. Our results suggest that random
allelic expression imbalance is established during lineage commitment and is associated with increased DNA methylation at
the gene promoter.
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INTRODUCTION
Although autosomal genes are predominantly expressed
from both the maternal and paternal alleles, examples of al-
lelic imbalance or monoallelic expression have been de-
scribed. Genotype-associated allelic imbalances, regulated
by expression quantitative trait loci (eQTLs) in cis, are ac-
knowledged to be a widespread source of phenotypic varia-
tion in humans (Ge et al. 2009) and mouse (Crowley et al.
2015). Monoallelic expression can also be epigenetically con-
trolled in a parent-of-origin specific manner, as exemplified
by genomic imprinting (Reik and Walter 2001), a relatively
rare phenomenon affecting approximately 100 genes in
human and 120–180 genes in mouse (Babak et al. 2015;
Baran et al. 2015; Crowley et al. 2015). Monoallelic gene ex-
pression can also be random, whereby a cell stochastically
expresses a single allele. This phenomenon has been well
described in female mammalian cells, which transcriptional-
ly inactivate the majority of genes on one randomly chosen
X chromosome (Lyon 1986; Carrel and Willard 2005).
X-chromosome inactivation occurs during the morula to
blastocyst stage and is epigenetically maintained during
subsequent mitotic cell divisions (Deng et al. 2014). Autoso-
mal genes can also undergo random monoallelic expression,
with initial descriptions of its occurrence in immune genes
(Mostoslavsky et al. 2001) and the olfactory receptors (Chess
et al. 1994), providing cellular diversity within these systems.
Recent high-throughput allelic expression profiling of hu-
man clonal lymphoblastoid, fibroblast, and neural stem cells
has shown that stochastic allelic expression is more prevalent
than previously thought, affecting up to 10% of autosomal
expressed transcripts across a diverse range of cell types
(Gimelbrant et al. 2007; Chess 2012; Jeffries et al. 2012; Li
et al. 2012; Zwemer et al. 2012). This process has also been
observed in mouse, with a significant overlap in loci charac-
terized by random monoallelic expression across species
(Zwemer et al. 2012). The cellular diversity resulting from
such stochastic monoallelic gene expression is likely to result
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in considerable clonal level phenotypic heterogeneity within
tissues.
Although complex multiple-promoter regulated expres-
sion drives the stochastic process of allelic choice in a limited
number of genes, for example the immune gene Ly49 and the
protocadherin clusters alpha and gamma (Ensminger and
Chess 2004; Chess 2005), the mechanisms driving most cases
of autosomal randommonoallelic expression are not known.
It has been shown that while biallelic genes are synchronously
replicated in S-phase, random monoallelically expressed
genes show asynchronous replication, even before the activa-
tion of transcription (Kitsberg et al. 1993; Simon et al. 1999).
Epigenetic processes such as DNA methylation and histone
modifications are also associated with this form of transcrip-
tional control (Jeffries et al. 2012; Nag et al. 2013). While in-
creased DNA methylation at the gene promoter is associated
with monoallelic gene expression (Gendrel et al. 2014), DNA
methylation on its own may not be sufficient for allelic ex-
pression control (Eckersley-Maslin et al. 2014; Gendrel
et al. 2014).
Stochastic monoallelic loci are distributed across the ge-
nome and encompass most functional gene ontologies, al-
though some studies indicate that they are enriched among
cell surface molecules (Gimelbrant et al. 2007; Jeffries et al.
2012). Two recent studies examined the developmental pat-
terns of random monoallelic expression using clonally ex-
panded embryonic stem cells (ES) and neural progenitor
cells from outcrossed mice (Eckersley-Maslin et al. 2014;
Gendrel et al. 2014). Approximately 0.5% of transcribed
genes in ES cells were characterized by random monoallelic
expression, compared to 2%–3% of expressed genes in de-
rived neural progenitor cells. There was little overlap in the
specific monoallelic genes between ES cells and neural pro-
genitor cells, although there was overlap between the neural
progenitor cells from the two studies (Eckersley-Maslin et
al. 2014; Gendrel et al. 2014; Reinius and Sandberg 2015).
Allelic expression has also been examined in human fibro-
blasts reprogrammed into induced pluripotent stem cells
(iPSCs) (Tanaka et al. 2015). A bias or allelic preference
was observed in a subset of genes during the intermediate
stage of reprogramming, with biallelic expression restored
when iPSC reprogramming is complete.
In this study, we examined the effects of epigenetic repro-
gramming on allelic expression decisions within a defined
clonal human neural progenitor cell line. We first quantified
the extent of random monoallelic expression and related this
to DNA methylation in fetal-derived clonal neural progeni-
tor cells. Subsequently, we assessed allelic patterns of gene
expression after epigenetic reprogramming into a pluripo-
tent state (Takahashi and Yamanaka 2006). Finally, the re-
sulting iPSCs were committed back into a neural lineage,
and clonal neural stem cells subsequently profiled. We
show, for the first time in human cells, the dynamic nature
of allelic expression patterns across pluripotent and lineage
committed states.
RESULTS
Epigenetic reprogramming to induced pluripotency
resets random allelic expression imbalance
To investigate the effect of epigenetic reprogramming to in-
duced pluripotency on stochastic allelic expression, we pro-
filed allelic expression patterns in three conditionally
immortalized clonal human neural stem cells (proliferative
state: SPC01, SPC04, and SPC06; and differentiated state:
SPC01D, SPC04D, and SPC06D) and reprogrammed iPSC
clones derived from one of these (SPC01). Two iPSC clones
were profiled (iPS1 and iPS2) at “early” (6–10 passages) and
“late” (20–22 passages) passages (see Supplemental Fig. S1
for an overview of our experimental design). Approximately
7000 autosomal genes contained informative (heterozygous)
transcribed SNPs (see Materials and Methods) allowing us
to make quantitative allelic expression measurements. Based
on previous allelic expression studies (Pastinen et al. 2004;
Serre et al. 2008; Lee et al. 2009; Jeffries et al. 2012) and X-
chromosome inactivation profiles (Supplemental Fig. S2),
we categorized the expression of genes as biallelic (BA), alleli-
cally skewed, andmonoallelic (MA) according to the degree of
allelic bias detected. A summary of the allelic expression pat-
terns for all clonal lines profiled in this study is shown in Table
1A together with the changes in allelic expression between dif-
ferent developmental states shown in Table 1B–D. More de-
tailed alternate isoform level results for each developmental
state are shown in Supplemental File S1. We also identified
a number of genes characterized by MA expression in one
clone but BA expression in other clones of the same develop-
mental state. We describe these as random allelic expression
imbalanced genes (the term random monoallelic expression
would be assigned if both alleles were detected in additional
clones examined). The frequency of these genes is shown in
Table 1, and lists of MA genes in Supplemental File S2.
In the clonal neural stem cells, 138 nonimprinted autoso-
mal genes (1.88% of total assessed genes) were characterized
as demonstrating MA expression (i.e., allelic ratio >2.85-fold,
see Materials and Methods), of which 46 (0.63% of total as-
sessed genes) showed evidence of random allelic expression
imbalance based on differing allelic expression profiles in sis-
ter clones. Our subsequent analyses focused primarily on the
representative clone SPC01, which was characterized by 79
autosomal MA-expressed genes, not known to be genomi-
cally imprinted. By examination of the two sister clones for
alternative allelic expression profiles, we conservatively esti-
mate that 23 (29% of SPC01 expressed MA genes) show
evidence of random allelic expression imbalance. After epige-
netic reprogramming to induced pluripotency, 20 of these
random allelic expression imbalanced genes were expressed
at detectable levels in the resultant iPSC clones. Strikingly,
17 (85%) of these initial random allelic expression imbal-
anced loci showed clear BA expression after reprogramming
(Table 1B; Fig. 1A). Allelic expression measurements were
successfully validated by single nucleotide primer extension
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assays at all loci tested (Fig. 1B). While reprogramming in-
volves a number of cell signaling pathways, the widespread
epigenomic changes that occur during reprogramming
(Koche et al. 2011; Polo et al. 2012) give support toward a
role for epigenetic processes regulating random allelic expres-
sion imbalance.
An additional 56 MA gene loci detected in the SPC01 cell
line could not be unequivocally identified as being character-
ized by random allelic expression imbalance because either
the same allele was expressed in all three sister clones or ex-
pression was not reliably detected in all clones (see Fig. 1C).
Examining their response to reprogramming revealed that
TABLE 1. Summary of allelic expression profiles for the clonal cell lines in this study















Clonal neural stem cells
SPC01/SPC04/SPC06 7312 149 138 46 3
SPC01D/SPC04D/SPC06D 7523 114 100 39 3
Before epigenetic reprogramming
SPC01 6531 90 79 23 3
SPC01 differentiated 2 wk 6997 58 46 16 3
After epigenetic reprogramming of SPC01
iPS1 early passage 7259 55 48
9
3
iPS1 late passage 7333 52 45 3
iPS2 early passage 6930 31 24 2
iPS2 late passage 7303 43 36 3
Clonal neural stem cells from iPS clones 1 and 2
NSC1a/NSC1b/NSC1c 7122 75 66 24 2
NSC2a/NSC2b 7176 105 96 8 1
NSC2 polyclonal 7391 37 29 - 1
(B) iPSC
BA MA AS MA and BA NE
SPC01 RAI 23 17 1 1 1 3
SPC01 MA 56 26 20 5 0 5
(C) SPC01
MA BA AS NE
iPSC MA 68 22 23 8 15
(D) NSC1 - 66 monoallelic genes NSC2 - 96 monoallelic genes
MA BA AS NE MA BA AS NE
iPS1 early 11 35 5 15 iPS2 early 10 38 6 42
iPS1 late 11 35 6 14 iPS2 late 12 40 5 39
SPC01 13 26 7 20 SPC01 14 21 6 55
(A) Result summaries are shown for SPC01, SPC04, and SPC06 at proliferative and differentiated (denoted by “D”) states. Separate counts for
SPC01 are also shown since this was epigenetically reprogrammed and two induced pluripotent stem cells isolated (iPS1 and iPS2), collected
at early and late passages. Subsequent lineage commitment to a series of iPS-derived clonal neural stem cells is also shown (NSC1a 1b and
1c derived from iPS1 and NSC2a and 2b from iPS2). A polyclonal cell line is also shown derived from iPS2. The values shown indicate the
total number of genes assessed, the number of loci characterized by at least one clone with MA expression, and the number of loci showing
random allelic expression imbalanced genes. The number of technical replicates for each cell line is also shown.
(B) Random allelic imbalanced (RAI) and other monoallelic genes (MA) observed in SPC01 and their allelic status after epigenetic reprogram-
ming into iPSCs. Allelic skewing (AS), nonexpressed genes (NE), and iPSC-based gene expression with alternate MA and BA in each clone
(MA & BA) are also shown.
(C) How the 68 monoallelic genes detected in both iPSC clones (see main text) are represented in SPC01 prior to reprogramming.
(D) Two tables showing how monoallelic gene expression detected in iPSC-derived NSC clones are represented in their corresponding iPSC
clones as well as the original SPC01 prior to reprogramming.
Jeffries et al.
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26 of the 56 genes (46%) reverted to BA expression in the
iPSCs (Table 1B), while the remaining 30 transcripts were
characterized by stable MA expression (20 genes/36%), allelic
skewing (five genes/9%), or no detectable expression (five
genes/9%) after epigenetic reprogramming. Therefore, the
remodeling of epigenetic marks during reprogramming to a
pluripotent developmental state appears to erase the MA ex-
pression status of most random allelic expression imbalanced
genes and ∼50% of the additional 56 MA expressed genes
that are likely to contain additional random allelic expression
imbalanced genes. The genes that remain MA after repro-
gramming are likely to represent loci showing a resistance
to epigenetic reprogramming (Chen et al. 2013a) or examples
of genetically driven MA expression—
i.e., cis-acting expression quantitative
trait loci (eQTLs) (Ge et al. 2009). To in-
vestigate this further, we cross-referenced
these genes to loci characterized by aber-
rant gene expression in iPS cells (Chin
et al. 2009) and found no overlap. We
also checked 841 genes mapping to
known hotspots of aberrant epigenetic
reprogramming defined by DNAmethyl-
ation differences between iPSCs and em-
bryonic stem cells (Lister et al. 2011).
Five of these genes (DPP6, FTCD,
HEATR4, LRRC61, and MYH14) were
present in our list of 22 constant MA ex-
pressed genes. This represents about
twice as many genes as would be expect-
ed by chance but does not represent a
statistically significant enrichment (two-
tailed Fisher’s exact test P-value = 0.41).
From this, we conclude that it is likely
that the majority of MA expressing genes
that fail to respond to the reprogram-
ming actually represent examples of ge-
netically driven MA expression.
We also examined an additional 23
random allelic expression imbalanced
genes, characterized by BA expression
in the SPC01 cell line but MA expression
in either of the sister clonal lines (SPC04
or SPC06). Of these genes, 20 showed
measurable expression in the iPS state,
all with biallelic expression except
NLRP2, which showed random allelic ex-
pression imbalance. After neuralization,
the majority of the genes maintained
BA expression apart from NLRP2, which
showedMA expression, and SYT3, which
was characterized by skewed allelic ex-
pression in two neural stem cell clones.
Novel monoallelic gene expression
in reprogrammed iPSCs
Allelic expression profiling of the two iPSC clones at early
and late passage identified 68 genes (0.88% total genes as-
sayed) characterized by MA expression in at least one iPSC
clone (iPS1 early and late passage clones = 62 genes, iPS2 ear-
ly and late passage clones = 39 genes, overlap between two
IPSC clonal sets = 33 genes). Of these, 22 genes were charac-
terized as being MA in the original SPC01 cell line before re-
programming, suggesting that their allelic expression status is
resistant to epigenetic reprogramming or influenced by cis-
acting genetic factors. The remaining 46 genes (0.59% of total
genes assayed) potentially indicate de novo MA expression
FIGURE 1. Changes in allelic expression are seen across different developmental states. (A)
Allelic expression profiles for genes identified as monoallelically expressed in the SPC01 neural
stem cell. Allelic expression is shown for SPC01, SPC04, and SPC06 at proliferative and differen-
tiated states (denoted with “D”) as well as its resulting iPS clones at early and late passage (labeled
“Early” and “Late”), together with iPS-derived clonal NSC’s and a polyclonal cell isolate (labeled
“pc”). Genes have been categorized into two groups—those positively identified as showing ran-
dom allelic expression imbalance and those which only show MA expression in measured clones.
The abbreviation SK indicates genes showing allelic skewing. (B) Validation of the resetting of
monoallelic expression detected in SPC01 to a more biallelic form of allelic expression in iPSC
clones. The percentage expression of the major expressed allele is shown in relation to the high-
lighted regions indicating monoallelic and biallelic expression. “S” denotes the SNaPshot primer
extension assay results and “A” denotes the allelic expression results from the Illumina beadchip.
(C) MA genes found in the epigenetically reprogrammed iPSCs. (D) MA genes identified in the
iPSC-derived neural stem cells. See Supplemental Figure S3 for high-resolution heatmaps.
Allelic expression after epigenetic reprogramming
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emerging at the pluripotent state since 50% of these (23
genes) were previously characterized by BA expression in
SPC01 clones before reprogramming (in the proliferative or
differentiated state), with the remaining genes showing clear
allelic imbalance (eight genes/17.4%) or levels of expression
below detection (15 genes/32.6%).
More detailed analysis of the individual clones and
comparison of passage number highlighted nine genes
(CACNB2, DNAJA4, RBFOX1, LOC647946, MYH14,
NLRP2, TCERG1L, and SYCP2L) characterized by apparent
random allelic expression imbalance as demonstrated by
MA expression in one iPSC clone and BA expression in the
other clone. One of these loci, RBFOX1, is an RNA-binding
protein associated with autism (Sebat et al. 2007). This
gene shows similar random allelic expression imbalance in
a previous allelic expression study examining iPSCs and dif-
ferentiated neurons (Lin et al. 2012). Furthermore, two
genes, ZNF528 and PKIB, while consistently characterized
by BA expression in iPS1 and early passage iPS2 cells, con-
verted to MA expression in late passage iPS2 clones.
Interestingly, the MA expression of PKIB was maintained
in the resulting iPSC-derived NSC2 (both clonal and poly-
clonal), whereas ZNF528 reverted back to BA expression.
Neuralization reestablishes random allelic
expression imbalance
The majority (85%) of random allelic expression imbalanced
genes identified in the original SPC01 neural stem cells re-
verted to BA expression after epigenetic reprogramming to
induced pluripotency. To explore what happens when these
iPSCs are recommitted to a more restricted neural progenitor
cell lineage, we neuralized two iPSC clones using a dual
SMAD inhibition method (see Materials and Methods) to
produce rosette-like neural stem cells (Chambers et al.
2009). We subsequently sequenced cDNA for previously
identified random allelic expression imbalanced genes, iden-
tifying BA expression signatures in the iPSC-derived neural
stem cells (Supplemental Fig. S4) as would be expected since
this population of neural cells is polyclonal, derived from
multiple individual neuralized cells.
We subsequently isolated clonal cell lines by dilution plat-
ing of this polyclonal population, and cultured the surviving
colonies to a sufficient density for RNA isolation and profil-
ing. Five neural stem cell clones were isolated in total (three
from one iPS1 clone [termed NSC1] and two from a second
iPS2 clone [termed NSC2]) in addition to the polyclonal
population sample. Approximately 7100 genes were informa-
tive for allelic expression profiling, of which 66 nonimprinted
autosomal genes (0.93% of total assayed genes) were identi-
fied as being characterized byMA expression in at least one of
the NSC1 clones. Ninety-six MA-expressed genes (1.34% of
total assayed genes) were identified in the NSC2 clone set, al-
though the lack of a technical replicate in this latter set may be
one reason for the higher call rate. Examining the overlap
between clone sets, 37 (58.7%) of 63 genes expressed in
both clonal sets showed evidence of MA expression in both
NSC1 and NSC2 clones. Many of these NSC1 and NSC2
genes represent novel MA loci and were not characterized
by MA expression in the original SPC01 line. The limited
gene ontology analyses we could undertake given the small
number of input loci provided evidence for an overrepresen-
tation of proteins integral to the plasma membrane
(GO:0005887, P = 0.04, 1.97-fold enrichment), reflecting
the patterns seen in the original clonal neural stem cell before
reprogramming in addition to neural stem cells from other
brain regions (Jeffries et al. 2012) and clonal lymphoblastoid
cells (Gimelbrant et al. 2007).
Using the clonal results, we estimated the frequency of ran-
dom allelic expression imbalance identifying alternate allelic
expression patterns across clones. Individually, 24 random
allelic expression imbalanced genes were identified in the
NSC1 clones (36.4% of total MA genes identified within
the three clones) and eight in NSC2 (8.3% of total MA genes
from two clones). Combining NSC1 and NSC2 to give five
clones showed 7334 total genes expressed, with 126 genes
(1.71%) showing at least one clone with MA expression
and 48 of these (0.65% of total expressed genes) displaying
random allelic expression imbalance. An alternate approach
to estimate the frequency of random allelic expression imbal-
ance is to examine a polyclonal population in combination
with clonal cells. Since random allelic expression imbalance
choice appears to be a stochastic process, measurements in
polyclonal populations are expected to show approximately
equal quantities of both alleles, i.e., apparent BA expression.
We found that 42 of the 48 (88%) random allelic expression
imbalanced genes identified in the five clones of NSC1 and
NSC2 were characterized by a BA signal when examined in
polyclonal neural stem cells. The polyclonal neural stem
cell showed measurable expression for 88 of the 126 MA ex-
pressed genes identified in the NSC1 and NSC2 clones. From
these, 62 genes (70.5%) were characterized by BA expression
in the polyclonal cell line, indicating a higher frequency of
0.84% of total expressed genes showing random allelic ex-
pression imbalance frequency compared to our estimate of
0.65% using clonal lines alone. Seventeen genes were also
identified as being MA expressed (19.3%) in the polyclonal
line, with nine genes with allelic skewing (10.2%), pre-
sumably influenced by cis-acting genetic effects. Based on
our data, we conclude that lineage commitment commits
approximately 1.7% of genes to MA expression, of which be-
tween 0.65% and 0.84% of expressed genes are characterized
by random allelic expression imbalance.
DNA methylation correlates with allelic status
Global patterns of DNA methylation (Fig. 2A,B) show only
modest changes associatedwithdevelopmental state, although
we observe large changes in DNAmethylation at specific CpG
sites; 40,425 CpGs of 415,863 were characterized by >30%
(Δβ > 0.3) differences in DNA methylation between SPC01
Jeffries et al.
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and iPSCs before and after reprogramming. Increased levels of
non-CpG site DNA methylation were also found during the
pluripotent iPSC stage (Fig. 2C,D) compared to neural stem
cells before and after reprogramming. Hierarchical clustering
based on CpG and non-CpG sites distinguished the different
clonal developmental states used in this study (Fig. 2E,F).
Overall, the DNAmethylation changes described are in agree-
ment with expected changes reported from a previous study
examiningmultiple tissue types and their reprogrammed plu-
ripotent counterparts (Nishino et al. 2011).
Building on our previous evidence for increased levels of
DNA methylation associated with random MA expressed
genes (Jeffries et al. 2012), we compared DNA methylation
in iPSC-derived NSC clones showing MA expression to
clones showing BA expression, identifying dramatic differ-
ences at numerous loci. For example, TNFRSF10D, which
we previously reported as showing random allelic expression
imbalance (Jeffries et al. 2012), is significantly hypomethy-
lated in reprogrammed iPSC compared to the MA expressing
SPC01 cell line across all probes associated with an exon
spanning CpG island (average DNA
methylation difference = 19.9%, paired
t-test P-value = 0.015) (Supplemental
Fig. S6). Lineage commitment associated
with skewed allelic expression is charac-
terized by increased DNA methylation
at this locus, whereas a clone with no
detectable expression is characterized by
even higher DNA methylation levels.
Overall, three broad classes of genic
region were characterized by differences
in DNA methylation within MA express-
ing clones compared to BA clones (Fig.
3; Supplemental Table S1). Increased
DNA methylation was found in MA ex-
pression clones at regions ∼200 bp up-
stream of the transcriptional start site
(paired Wilcoxon rank sum test P-value
= 0.006), indicative of differential meth-
ylation at the gene promoter, and similar
increased expression at the first exon
(paired Wilcoxon rank sum test P-value
= 3.726 × 10−7). The gene body, in con-
trast, showed decreased DNA methyla-
tion in MA expressing clones (paired
Wilcoxon rank sum test P-value =
0.003458). These observations of in-
creased DNA methylation at the pro-
moter and decreased levels within the
gene body are interesting given the re-
pressed transcriptional activity of MA
expressed genes (Jones 2012). We also
examined DNA methylation across an-
notated CpG island features. CpG island
shelves and shores showed no statistically
significant difference. However, more
dramatic differences in DNA methyla-
tion were observed within actual CpG is-
lands, with significantly increased DNA
methylation associated with MA expres-
sion (paired Wilcoxon rank sum test P-
value = 4.799 × 10−10).
Previous studies have also shown an
association with other epigenetic signa-
tures (Jeffries et al. 2012; Nag et al.
FIGURE 2. Monoallelic gene expression is associated with elevated levels of DNA methylation.
Autosomal DNAmethylation profiles are shown for SPC01 neural stem cell, induced pluripotent
stem cells (iPSs), and iPSC-derived neural stem cells (NSCs). (A) DNA methylation levels at au-
tosomal CpG sites. (B) The methylation β-value distribution changes for autosomal CpG sites in
the different developmental cell types studied. (C) Levels of DNA methylation at 2902 autosomal
non-CpG sites. Significant increases in DNAmethylation can be seen in iPS cells when compared
to the original donor SPC01 neural stem cell and also resulting iPS-derived NSCs. (D) Scatterplot
illustrating similar status of non-CpG DNA methylation of iPS-derived NSCs versus the original
SPC01 NSC. (E) Heatmap of DNA methylation values for autosomal CpG sites together with hi-
erarchical clustering of each sample. (F) Heatmap of DNAmethylation values for non-CpG sites.
Additional DNA methylation data are shown in Supplemental Figure S5.
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2013; Eckersley-Maslin et al. 2014; Gendrel et al. 2014). To
investigate this further, we utilized reference human epige-
nomes (Roadmap Epigenomics Consortium et al. 2015) for
human ES cells (H1 and H9) as well as ES-derived neural
progenitor cells. Gene loci showing monoallelic expression
or random allelic imbalance in our iPS-derived NSCs from
this study showed significantly decreased levels of the active
chromatin marks H3K4me3 and DNase I hypersensitivity
sites (Supplemental Fig. S7) in both pluripotent ES cell
and neural progenitor cell reference epigenomes. Conversely,
significantly increased levels of the repressive H3K27me3
were observed for these genes when compared to biallelic
gene loci. To investigate whether developmental-specific
differences were present, we selected gene loci showing
biallelic expression in iPS1 and concomitant monoallelic
expression in at least one of the iPS1-derived NSC1 clones
(Supplemental Fig. S8). Increase levels of H3K4me3 were
found in both the H1 and H9 ES cell lines when compared
to the neural progenitor derivatives (Wilcoxon rank sum
P-value <2.2 × 10−16). However, conflicting results were
found for the repressive H3K27me3 modification, with H1
ES cells showing higher levels than their neural progenitor
counterparts compared to H9 neural progenitors showing
higher levels than their original ES cell status (Wilcoxon
rank sum P-value <2.2 × 10−16). No differences were ob-
served at DNase I hypersensitivity sites (Wilcoxon rank
sum P-value = 0.78).
DISCUSSION
The aim of this study was to assess the effects of induced plu-
ripotency on genes characterized by random allelic expres-
sion imbalance. We show that the majority of random
allelic expression imbalanced genes with initial MA expres-
sion were reset to a BA status when reprogrammed. After
lineage commitment back into a neural stem cell state, MA
expression was reestablished in some of the original MA
genes, in addition to many new genes that had been BA-
expressed prior to reprogramming. We also observed some
de novo MA expression arising in the iPSC clones, perhaps
representing partial commitment to random allelic expres-
sion imbalance or simply reflecting a dynamic allele-specific
transcriptome. Similar de novo allelic expression bias was
also noted in another study examining human iPSC repro-
gramming stages (Tanaka et al. 2015) and murine ES cells
(Eckersley-Maslin et al. 2014; Gendrel et al. 2014).
The primary cause of monoallelic expression was original-
ly thought to be through genomic rearrangements based on
early cloning experiments of mature lymphocytes which
resulted in monoclonal mice containing the same rearranged
t-cell receptor gene in all tissues (Hochedlinger and Jaenisch
2002). However, nuclear transfer experiments of post-mitot-
ic olfactory neurons proved otherwise, showing allelic ex-
pression status was reset upon nuclear transfer (Eggan
et al. 2004; Li et al. 2004) resulting in cloned mice with a
full repertoire of olfactory receptors. Our experiment builds
on this and shows widespread resetting of monoallelic ex-
pression in genes undergoing random allelic expression
imbalance/random monoallelic expression control after re-
programming to pluripotency. Previous to this work, two
papers examining murine ES cells and derived neural pro-
genitor cells detected increased levels of random monoal-
lelic/imbalanced expression upon differentiation (0.5%
genes in ES cells versus 3% in neural progenitor cells). Our
study shows a lower estimate of random allelic imbalanced
expression in analogous iPSC cells and human neural pro-
genitor cells, which may reflect the lower number of clones
examined.
If the pluripotency and lineage committed results correctly
extrapolate in vivo, it suggests allelic expression assignment
occurs during either gastrulation or neurulation. An over-
representation of genes encoding cell surface/cell membrane
proteins was found among the MA-expressing loci, agreeing
with previous studies (Gimelbrant et al. 2007; Jeffries et al.
2012). Cell surface diversity may therefore be a factor driven
FIGURE 3. Monoallelic gene expressions are associated with increased
DNA methylation at the transcriptional start site and CpG island se-
quences. Violin plots illustrate the distribution of DNAmethylation lev-
els at autosomal CpG sites for random allelic expression imbalanced
genes in iPS-derived neural stem cell NSC1 clones expressed as either
MA (purple) or BA (cyan). (A) DNAmethylation levels at annotated re-
gions 1500 and 200 bp from the transcriptional start site (TSS1500 and
TSS200), 5′ and 3′ untranslated regions (5′UTR and 3′UTR), regions as-
sociated with the first exon (1st Exon) and those within the gene body
(Body). Significantly increased DNA methylation was found in MA ex-
pressing clones at the TSS200 region (Wilcoxon rank sum P-value =
0.00601) and 1st Exon (P = 3.726 × 10−7). The gene body also showed
increased DNA methylation in BA clones (P = 0.003458) (B) CpG
Island features show significantly increased DNA methylation was asso-
ciated with MA expressed genes within CpG Islands (P = 4.799 × 10−10)
rather than the shores and shelves.
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by random allelic expression imbalance, allowing alternate
isoforms that may encode functional differences to be ex-
pressed in a subset of cells. This process would also provide
a mechanism to support dosage variation, a phenomenon
previously associated with monoallelic expression (Gimel-
brant et al. 2007; Jeffries et al. 2012; Li et al. 2012). This
may have profound implications for tissues such as the brain
where cell identity and cell migration are highly dependent
on receptor–ligand or receptor–morphogen interactions. As
previously hypothesized, it may also contribute to disease dis-
cordance observed in monozygotic twin-pairs (Jeffries et al.
2013; Oey et al. 2015).
Recent single cell gene expression analyses have shown ev-
idence for widespread monoallelic expression, although this
is often dynamic in nature, presumably from the stochastic
burst-like nature of transcription (Reinius and Sandberg
2015). However, mitotically stable random monoallelic ex-
pression (and allelic expression imbalance), as detected in
clonal cell line studies such as in this study, is more likely me-
diated by epigenomic modifications. We and others find dif-
ferential promoter level DNA methylation, a reduction of
active chromatin signatures and increased repressive histone
modifications associated with many random monoallelic ex-
pressed loci (Jeffries et al. 2012; Eckersley-Maslin et al. 2014;
Gendrel et al. 2014). However, use of 5-azacytidine to deplete
cells of DNAmethylationmarks failed to alter MA expression
in examined candidate genes (Eckersley-Maslin et al. 2014;
Gendrel et al. 2014). This observation has some similarities
to a study in mouse embryonic fibroblasts which examined
imprinted genes after 5-azacytidine exposure (El Kharroubi
et al. 2001). Exposure altered allelic expression in some im-
printed genes but failed to have an impact on other imprinted
gene loci (El Kharroubi et al. 2001), indicating differences
in allelic regulation mechanisms between some of the im-
printed MA expressed genes. It is uncertain whether random
monoallelic expressed genes throughout the genome are reg-
ulated in the same way or have differences in control mech-
anisms. Regardless, these data indicate that an additional
layer of epigenetic control, such as histone tail modifications
or antisense RNA, may play a role in regulating monoallelic
expression.
In conclusion, we provide evidence to support the notion
that random or stochastic MA expression is a form of tran-
scriptional control, which is set early in development during
lineage commitment. The reprogramming of cells to an
embryonic stem-cell-like state erases this form of transcrip-
tional control but directed commitment to a neural stem
cell lineage promotes its reassignment at a number of genes.
Specific loci may show an inherent susceptibility to random
allelic expression imbalance, with genes encoding cell sur-
face molecules being particularly affected by this form of
transcriptional control. Increased DNA methylation at the
gene promoter, particularly across CpG Islands, is associated
with monoallelic expressing clones and may play a key role in
maintaining the repression of the inactive allele.
MATERIALS AND METHODS
Cell culture and derivation of induced pluripotent
stem cells and neural stem cells
Conditionally immortalized human neural stem cell lines were de-
rived from 10-wk-old fetal cervical spinal cord as described in
Cocks et al. (2013). Three clones were used in this study (SPC01,
SPC04, and SPC06) in their proliferative state, or following 2 wk
of neural differentiation in culture (SPC01D, SPC04D, and
SPC06D), which gives rise to a population of neurons and glia.
The SPC01 cell line was epigenetically reprogrammed using a lenti-
viral vector to express OCT4, SOX2, KLF4, and c-MYC. Clones were
isolated and pluripotency checked through the gene expression-
based PluriTest (Müller et al. 2011) and immunocytochemistry
for the pluripotency markers (Supplemental Fig. S9). Two iPS
clones were carried forward in this study (iPS1 and iPS2), with early
(6–10) and late (20–22) passage clones collected for analysis. Neural
stem cells were also derived from the two iPSC clones using a dual
SMAD inhibition procedure as described by Chambers et al. (2009).
Clones were isolated through serial dilution into 96-well plates of
single cells followed by expansion up to six-well plates for RNA
and DNA harvesting. Expansion and subsequent profiling of two
replicate wells was possible with NSC1 clones, although only one
well was available for the NSC2 clones. This may result in higher in-
cidence of false positives in the NSC2 clones.
Nucleic acid isolation
RNA was collected and extracted using TRIzol (Life Technologies)
followed by DNase treatment (DNA Turbo free, Life Technologies).
DNase-treated RNA quality was assessed with the Agilent
Bioanalyser (RIN > 9) and quantitative PCR on 200 ng of RNA to
ensure no remaining genomic DNA. One microgram of RNA was
converted to cDNA using random hexamers and Superscript III re-
verse transcriptase (Life Technologies) at 42°C for 2 h. Genomic
DNA was extracted from cell pellets by incubation in sodium chlo-
ride-Tris-EDTA buffer containing 0.5% SDS with RNaseA (10 µg/
mL) for 45 min at 37°C followed by Proteinase K (0.2 mg/mL) ad-
dition and further incubation at 50°C for 120 min. Phenol/chloro-
form extraction was then performed.
Allelic expression analysis
We carried out a genome-wide allelic expression analysis using
methods previously described in Jeffries et al. (2012). Briefly, the
Illumina HumanOmniExpress-12 SNP beadchip was used to assess
allelic expression using 250 ng of genomic DNA and cDNA equiv-
alent of 200 ng of RNA. The resulting cDNA and gDNA results
were separately quantile normalized across both channels before
analysis. Any probes where the sum of X + Y (representing the
scanned intensity for each allele) exceeded 750 were included in
the analysis. Those below 750 were excluded as background signal
noise. A β value of X/(X + Y) was then calculated to provide a quan-
titative scale of allelic expression rather than a binary assignment
from standard genotyping software. The difference or Δβ value be-
tween cDNA measurements versus genomic DNA heterozygous
SNPs was then used to calculate allelic expression at SNP probes,
and the mean absolute Δβ value of all informative SNPs for
RefSeq gene results. Intronic SNPs with sufficient intensity above
Allelic expression after epigenetic reprogramming
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background signal were included in the analysis since they also pro-
vide accurate allelic expression measurements (Pastinen et al. 2004;
Gimelbrant et al. 2007; Serre et al. 2008). Allelic expression assign-
ments were made according to the degree of allelic imbalance de-
tected. MA expression is indicated by a 2.85 or greater difference
in allele expression ratios (Δβ > 0.2), allelic expression skewing as
a 1.5–2.85 (Δβ > 0.1 and Δβ < 0.2), and biallelic expression (BA)
for those genes with a 1.0–1.5 ratio between alleles (Δβ < 0.1).
The Δβ SNP probe distribution for autosomes compared to the X
chromosome (containing a high number of inactivated/monoallelic
expressed genes) is shown in Supplemental Figure S2 and highlights
the use of Δβ > 0.2 being an appropriate threshold for MA expres-
sion. A penalty weighting score was also applied to minimize bias
of large transcripts, described in more detail in Jeffries et al.
(2012). Transcript-based analysis was performed in an isoform-spe-
cific manner. Known imprinted genes, as identified through gen-
eimprint (http://geneimprint.com), catalog of imprinted genes
(http://gc.otago.ac.nz) and a study by Morcos et al. (2011), were ex-
cluded from the primary analysis although are described in
Supplemental Figure S10. Similarly, chromosome X status is de-
scribed in Supplemental Figure S11. The α and γ protocadherins
were detected as showing random monoallelic expression in this
study but were removed from analysis to avoid bias based on their
overlapping genome annotations. The lack of a technical cell culture
well replicate in the NSC2 set is likely to account for the increased
number of genes detected in this sample set (see Materials and
Methods). All statistics were performed in R statistical environment
3.0.2 (R Development Core Team 2005) and gene ontology enrich-
ment analysis was performed using DAVID (http://david.abcc.
ncifcrf.gov/). Analyses looking for the presence of constitutive MA
gene expression within possible regions of abberant reprogramming
were performed using defined gene lists from Chin et al. (2009) and
genomic regions from Lister et al. (2011), the latter of which were
mapped to genes using GALAXY (https://usegalaxy.org). DNA se-
quence analyses were carried out using EpiGraph (http://epigraph.
mpi-inf.mpg.de).
Validation of allelic expression biases
Single-nucleotide primer extension analysis (SNaPshot, Applied
Biosystems) was used to validate allelic expression biases identified
using the SNP array. PCR amplification was performed on three ge-
nomic DNA samples and three independent reverse transcribed
cDNA samples. Four microliters of each PCR reaction were electro-
phoresced and visualized on agarose gels to confirm specific ampli-
fication. Five microliters of PCR reactions were then treated with 1
U shrimp alkaline phosphatase (GE Healthcare) and 2 U Exonucle-
ase I (New England Biolabs) at 37°C for 45 min and then at 85°C for
15 min prior to primer extension reactions. Primer extension reac-
tions were then carried out on the treated PCR products in a total
volume of 10 µL, containing 2 µL treated PCR product, 1.25 µL
SNaPshot reagent (Applied Biosystems), 5.75 µL H2O and 1 pM ex-
tension primer. Primer extension thermocycling conditions consist-
ed of an initial step of 95°C for 2 min, followed by 30 cycles of 95°C
for 5 sec, 43°C for 5 sec and 60°C for 5 sec. Aliquots of 2 µL SNaP-
shot reaction product were combined with 8 µL Hi-Di formamide
(Applied Biosystems) and electrophoresced on a 3130 Genetic Ana-
lyzer (Applied Biosystems). Peak heights of allele-specific extended
primers were determined using GeneMarker software (SoftGe-
netics) and the ratio of the two peak heights calculated for each re-
action to determine a β-value similar to the allelic expression
assessments from the genome-wide allelic expression profiling.
Epigenetic analysis
For DNA methylation analyses, genomic DNA (500 ng) from each
sample was treated in duplicate with sodium bisulfite using the
Zymo EZ DNA Methylation-Lightning Kit (Zymo Research).
Genome-wide DNA methylation was quantified using the Illumina
InfiniumHumanMethylation450 BeadChip (Illumina) and scanned
on the HiScan System (Illumina). Illumina GenomeStudio software
(Illumina) was used to extract signal intensities for each probe, gen-
erating a final report that was imported into the R statistical environ-
ment 3.0.2 (R Development Core Team 2005) using the methylumi
and minfi packages (http://bioconductor.org/packages). Data quali-
ty control and preprocessing were performed using the wateRmelon
package as described previously (Pidsley et al. 2013). Cross hybrid-
izing probes (Blair and Price 2012; Chen et al. 2013b) were removed
from the analysis.
For our analysis of histone modifications and DNase I hyper-
sensitivity sites, data generated from H1 and H9 ES cells as well as
H1- and H9-derived neural progenitor cells using ChIP-seq and
DNase I hypersentivity site mapping experiments were derived
from release 9 of the preprocessed reference human epigenome da-
tabase (http:// egg2.wustl.edu/roadmap/web_portal/) generated by
the NIH Roadmap Epigenomics Mapping Consortium (Roadmap
Epigenomics Consortium et al. 2015). The corresponding −log10
Poisson P-values representing gene promoter regions (1000 bp up-
stream and 500 bp downstream of the transcriptional start site) were
obtained from this resource and compared within R using boxplots
and Wilcoxon rank sum tests.
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